Kynam Capital Management LP's Q3 2022 13F: 4 new positions, 2 exits
Form 13F-HR for the quarter ended Sep 30, 2022 · filed Nov 14, 2022 · 33 reported positions · accession 0001085146-22-004005
What changed this quarter
| Activity | Security | Weight before | Weight now | Change | Shares | Shares % |
|---|---|---|---|---|---|---|
| Reduced | GLOBAL BLOOD THERAPEUTICS IN (GBT) | 18.1% | 1.9% | −16.2 pts | −2.07M sh | −94% |
| Increased | NATERA INC (NTRA) | 11.3% | 18.7% | +7.4 pts | +779K sh | +63% |
| New | UNITED THERAPEUTICS CORP DEL (UTHR) | — | 6.7% | +6.7 pts | +151K sh | new |
| Reduced | GOSSAMER BIO INC (GOSS) | 5.1% | 1.0% | −4.1 pts | −1.96M sh | −84% |
| New | SANOFI (SNY) | — | 4.8% | +4.8 pts | +600K sh | new |
| Reduced | TRAVERE THERAPEUTICS INC (TVTX) | 7.7% | 2.2% | −5.6 pts | −818K sh | −66% |
| New | GSK PLC (GSK) | — | 3.1% | +3.1 pts | +500K sh | new |
| Increased | CELLDEX THERAPEUTICS INC NEW (CLDX) | 7.9% | 9.5% | +1.6 pts | +468K sh | +41% |
| Increased | VIRIDIAN THERAPEUTICS INC (VRDN) | 1.8% | 4.3% | +2.6 pts | +410K sh | +69% |
| Reduced | BIOCRYST PHARMACEUTICALS INC (BCRX) | 2.6% | 1.2% | −1.4 pts | −501K sh | −54% |
| Reduced | SYNDAX PHARMACEUTICALS INC (SNDX) | 12.5% | 11.5% | −0.9 pts | −239K sh | −10% |
| Increased | BURNING ROCK BIOTECH LTD (BNR) | 3.2% | 3.4% | +0.2 pts | +2.4M sh | +56% |
| Reduced | XENON PHARMACEUTICALS INC (XENE) | 1.4% | 0.2% | −1.2 pts | −146K sh | −84% |
| Increased | CONCERT PHARMACEUTICALS INC (CNCE) | 1.1% | 2.4% | +1.3 pts | +673K sh | +67% |
| New | PROTAGONIST THERAPEUTICS INC (PTGX) | — | 0.9% | +0.9 pts | +519K sh | new |
| Increased | SERES THERAPEUTICS INC (MCRB) | 0.2% | 1.0% | +0.8 pts | +514K sh | +199% |
| Increased | OLEMA PHARMACEUTICALS INC (OLMA) | 0.3% | 0.8% | +0.6 pts | +1.15M sh | +462% |
| Increased | AMARIN CORP PLC (AMRN) | 1.5% | 1.5% | 0.0 pts | +2.71M sh | +68% |
| Exited | MERUS N V (MRUS) | 0.6% | — | −0.6 pts | −104K sh | −100% |
| Exited | FATE THERAPEUTICS INC (FATE) | 0.5% | — | −0.5 pts | −81,064 sh | −100% |
| Reduced | AMICUS THERAPEUTICS INC (FOLD) | 2.5% | 1.5% | −1.0 pts | −223K sh | −25% |
| Increased | AKOUOS INC (AKUS) | 0.5% | 1.0% | +0.6 pts | +335K sh | +87% |
| Reduced | WAVE LIFE SCIENCES LTD (WVE) | 1.4% | 1.1% | −0.4 pts | −299K sh | −18% |
| Reduced | BIOGEN INC (BIIB) | 4.2% | 4.2% | +0.1 pts | −3,951 sh | −5% |
| Increased | LIQUIDIA CORPORATION (LQDA) | 1.7% | 1.9% | +0.3 pts | +192K sh | +13% |
| Reduced | VAXCYTE INC (PCVX) | 4.1% | 3.5% | −0.5 pts | −25,143 sh | −3% |
| Increased | VERA THERAPEUTICS INC (VERA) | 5.3% | 6.9% | +1.6 pts | +13,469 sh | +1% |
| Reduced | COGENT BIOSCIENCES INC (COGT) | 2.3% | 3.1% | +0.8 pts | −14,845 sh | −1% |
| Reduced | CENTESSA PHARMACEUTICALS PLC (CNTA) | 1.0% | 0.6% | −0.3 pts | −26,327 sh | −3% |
| Reduced | AFFIMED N V (AFMD) | 0.5% | 0.3% | −0.2 pts | −24,354 sh | −3% |
| Reduced | PUMA BIOTECHNOLOGY INC (PBYI) | 0.4% | 0.3% | −0.1 pts | −20,146 sh | −3% |
| Reduced | CABALETTA BIO INC (CABA) | 0.1% | 0.1% | −0.1 pts | −18,995 sh | −3% |
| Reduced | NEOLEUKIN THERAPEUTICS INC (NLTX) | 0.0% | 0.0% | 0.0 pts | −4,333 sh | −3% |
| Reduced | CATALYST BIOSCIENCES INC (CBIO) | 0.0% | 0.0% | 0.0 pts | −3,246 sh | −3% |
Reported by the fund in its Form 13F filed with the SEC; holdings are as of the quarter-end report date and may have changed since. For informational purposes only — not investment advice or a recommendation to buy or sell any security. FilingExplorer is not affiliated with or endorsed by this fund. How this brief is compiled
Top 10 positions — 73.6% of the equity book
Changes in the top 10 this quarter: UTHR entered · SNY entered · VRDN entered · GBT left · TVTX left · GOSS left
| # | Security | Weight before | Weight now | |
|---|---|---|---|---|
| 1 | NATERA INC (NTRA) | 11.3% | 18.7% | |
| 2 | SYNDAX PHARMACEUTICALS INC (SNDX) | 12.5% | 11.5% | |
| 3 | CELLDEX THERAPEUTICS INC NEW (CLDX) | 7.9% | 9.5% | |
| 4 | VERA THERAPEUTICS INC (VERA) | 5.3% | 6.9% | |
| 5 | UNITED THERAPEUTICS CORP DEL (UTHR) | 0.0% | 6.7% | Entered the top 10 |
| 6 | SANOFI (SNY) | 0.0% | 4.8% | Entered the top 10 |
| 7 | VIRIDIAN THERAPEUTICS INC (VRDN) | 1.8% | 4.3% | Entered the top 10 |
| 8 | BIOGEN INC (BIIB) | 4.2% | 4.2% | |
| 9 | VAXCYTE INC (PCVX) | 4.1% | 3.5% | |
| 10 | BURNING ROCK BIOTECH LTD (BNR) | 3.2% | 3.4% | |
| — | GLOBAL BLOOD THERAPEUTICS IN (GBT) | 18.1% | 1.9% | Left the top 10 |
| — | TRAVERE THERAPEUTICS INC (TVTX) | 7.7% | 2.2% | Left the top 10 |
| — | GOSSAMER BIO INC (GOSS) | 5.1% | 1.0% | Left the top 10 |
Weights are each position's reported value as a share of the fund's reported equity positions (options and principal-amount holdings excluded).
Option positions (puts and calls)
Reported separately from the positions above. The value a 13F reports for an option is that of the underlying shares, not the option itself.
| Activity | Security | Type | Shares before | Shares now | Reported value |
|---|---|---|---|---|---|
| Exited | CELLDEX THERAPEUTICS INC NEW (CLDX) | Call | 246K | 0 | $0 |
| Exited | ALNYLAM PHARMACEUTICALS INC (ALNY) | Put | 50,000 | 0 | $0 |
| New | RELMADA THERAPEUTICS INC (RLMD) | Put | 0 | 300K | $803K |
| Exited | KARUNA THERAPEUTICS INC (KRTX) | Put | 38,900 | 0 | $0 |
| New | TRICIDA INC (TCDAQ) | Call | 0 | 260K | $338K |
| New | TRICIDA INC (TCDAQ) | Put | 0 | 97,600 | $122K |
| New | LIQUIDIA CORPORATION (LQDA) | Call | 0 | 508K | $13K |